<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Five cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> were treated with <z:chebi fb="0" ids="28680">cytarabine</z:chebi> ocfosfate </plain></SENT>
<SENT sid="1" pm="."><plain>Ocfosfate (100-200 mg) was orally administered for 14 days with 14 days' interval </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="4911">Etoposide</z:chebi> was combined in one case, and nartograstim was added in two cases </plain></SENT>
<SENT sid="3" pm="."><plain>Two of the five cases achieved remission, one case having complete remission, and another case showing a good response </plain></SENT>
<SENT sid="4" pm="."><plain>Their remission durations were 141 and 112 days, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Further improvement of therapy is needed to achieve a higher remission rate and a longer remission duration </plain></SENT>
</text></document>